Division of Cancer Treatment and Diagnosis

E16765

The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.


Statements (45)
Predicate Object
instanceOf division of a government agency
research organization unit
affiliation U.S. Department of Health and Human Services
country United States
field cancer research
clinical oncology
drug development
medical diagnostics
oncology
translational research
focus biomarker development
cancer diagnosis
cancer treatment
clinical trials
combination cancer therapies
early-phase clinical trials
imaging technologies for cancer
precision oncology
therapeutic development
translational clinical research
goal to accelerate translation of laboratory discoveries into clinical applications
to expand access to innovative cancer treatments through clinical trials
to facilitate regulatory approval of effective cancer therapies
to improve outcomes for cancer patients
jurisdiction federal government of the United States
locatedIn Bethesda, Maryland
mission to support the clinical testing of new cancer diagnostic tools
to support the clinical testing of new cancer therapies
to support the development of new cancer diagnostic tools
to support the development of new cancer therapies
to support the evaluation of new cancer diagnostic tools
to support the evaluation of new cancer treatments
operatedBy National Cancer Institute
parentOrganization National Cancer Institute
National Institutes of Health
partOf National Cancer Institute
sector public sector
supports clinical trial networks
cooperative research groups
development of anticancer drugs
development of biologic cancer therapies
development of cancer diagnostic assays
development of cancer imaging agents
investigator-initiated clinical trials
website https://dctd.cancer.gov/

Referenced by (1)
Subject (surface form when different) Predicate
National Cancer Institute
hasDivision

Please wait…